Genus, Lannett Reach Deal To End Suit Over Cocaine Drug
A company that accused the U.S. Food and Drug Administration of improperly approving a Lannett Co. application for a cocaine-based numbing agent has told a District of Columbia federal judge that...To view the full article, register now.
Already a subscriber? Click here to view full article